glp 1 semaglutide or tirzepatide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from GLP-1 medications are marketed to

The goal is to stop before you feel overly full, not to clean the plate because the plate is there

We pride ourselves on creating individualized weight loss plans that consider your health history, lifestyle, and aspirations, all while offering the convenience of telehealth consultations

The Semaglutide Story: Highlighting the Need to Maintain Patent Protection in Canada Semaglutide, the blockbuster GLP-1 receptor agonist marketed under names like Ozempic (type 2 diabetes) and Wegovy (weight loss), has rapidly become one of the most consequential drugs in modern healthcare

Patients' Preferences for OnceDaily Oral Versus OnceWeekly Injectable Diabetes Medications: The REVISE Study

How Your Genetics Relate to GLP-1 Pathways Your baseline lipid panel and metabolic biomarkers provide crucial context for predicting potential GLP-1 treatment effects

The switch process is straightforward